30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

BONESUPPORT's CERAMENT G Approved by Health Canada -

BONESUPPORT received regulatory approval from Health Canada for CERAMENT® G gentamicin-eluting injectable ceramic bone graft substitute. The CE Marked product is presently the subject of FORTIFY, a multicenter 230-patient trial to assess improvement to the standard-of-care management of patients with open fractures of the tibial diaphysis. Positive data from FORTIFY will be used to support a Premarket Approval filing in the U.S., in anticipation of a 2021 launch. (BONESUPPORT, 8/16/18)